Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pieter L. Kubben is active.

Publication


Featured researches published by Pieter L. Kubben.


Lancet Oncology | 2011

Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review

Pieter L. Kubben; Karlien ter Meulen; Olaf E.M.G. Schijns; Mariel ter Laak-Poort; Jacobus J. van Overbeeke; Henk van Santbrink

We did a systematic review to address the added value of intraoperative MRI (iMRI)-guided resection of glioblastoma multiforme compared with conventional neuronavigation-guided resection, with respect to extent of tumour resection (EOTR), quality of life, and survival. 12 non-randomised cohort studies matched all selection criteria and were used for qualitative synthesis. Most of the studies included descriptive statistics of patient populations of mixed pathology, and iMRI systems of varying field strengths between 0·15 and 1·5 Tesla. Most studies provided information on EOTR, but did not always mention how iMRI affected the surgical strategy. Only a few studies included information on quality of life or survival for subpopulations with glioblastoma multiforme or high-grade glioma. Several limitations and sources of bias were apparent, which affected the conclusions drawn and might have led to overestimation of the added value of iMRI-guided surgery for resection of glioblastoma multiforme. Based on the available literature, there is, at best, level 2 evidence that iMRI-guided surgery is more effective than conventional neuronavigation-guided surgery in increasing EOTR, enhancing quality of life, or prolonging survival after resection of glioblastoma multiforme.


Surgical Neurology International | 2010

Neurosurgical apps for iPhone, iPod Touch, iPad and Android

Pieter L. Kubben

There is an abundance of useful content available in the App Store and Android Market for your mobile device, including medical content. Surgical Neurology International gladly supports the delivery of neurosurgical content on mobile devices with two active projects.


Neurosurgery | 2010

Intraobserver and Interobserver Agreement in Volumetric Assessment of Glioblastoma Multiforme Resection

Pieter L. Kubben; Alida A. Postma; Alfons G. H. Kessels; Jacobus J. van Overbeeke; Henk van Santbrink

BACKGROUND:The role of extent of tumor resection in improving outcome for patients with glioblastoma multiforme (GBM) is still under debate. OBJECTIVE:To analyze intraobserver and interobserver agreement of manual segmentation as a method for volumetric assessment of GBM resection. METHODS:Three observers performed volumetric assessment of preoperative tumor volume (PreTV) and postoperative tumor volume (PostTV) by manual segmentation on contrast-enhanced T1-weighted MRI data sets of 8 patients. Measurements were repeated after a minimum interval of 2 weeks. Intraobserver and interobserver agreement for PreTV, PostTV, and residual tumor volume (RTV) percentage were expressed in intraclass correlation coefficients (ICCs). RESULTS:Intraobserver agreement is high for PreTV (ICC = 0.99), PostTV (ICC = 0.73-0.94), and RTV (ICC = 0.89-0.94). Interobserver agreement is high for PreTV (ICC = 0.97), but low for PostTV (ICC = 0.54) and RTV (ICC = 0.52). CONCLUSION:Postoperative assessment of GBM volume seems to offer high intraobserver agreement, but low interobserver agreement. Using absolute RTV values to relate extent of tumor resection with survival may be unreliable. More research is needed before this method can be used as a valid end point for clinical studies. Computer-assisted tumor volume calculation may increase interobserver agreement in the future.


Surgical Neurology International | 2014

Intraoperative magnetic resonance imaging versus standard neuronavigation for the neurosurgical treatment of glioblastoma: A randomized controlled trial

Pieter L. Kubben; Félix Scholtes; Olaf E.M.G. Schijns; Mariel ter Laak-Poort; Onno P.M. Teernstra; Alfons G. H. Kessels; Jacobus J. van Overbeeke; Didier Martin; Henk van Santbrink

Background: Although the added value of increasing extent of glioblastoma resection is still debated, multiple technologies can assist neurosurgeons in attempting to achieve this goal. Intraoperative magnetic resonance imaging (iMRI) might be helpful in this context, but to date only one randomized trial exists. Methods: We included 14 adults with a supratentorial tumor suspect for glioblastoma and an indication for gross total resection in this randomized controlled trial of which the interim analysis is presented here. Participants were assigned to either ultra-low-field strength iMRI-guided surgery (0.15 Tesla) or to conventional neuronavigation-guided surgery (cNN). Primary endpoint was residual tumor volume (RTV) percentage. Secondary endpoints were clinical performance, health-related quality of life (HRQOL) and survival. Results: Median RTV in the cNN group is 6.5% with an interquartile range of 2.5-14.75%. Median RTV in the iMRI group is 13% with an interquartile range of 3.75-27.75%. A Mann-Whitney test showed no statistically significant difference between these groups (P =0.28). Median survival in the cNN group is 472 days, with an interquartile range of 244-619 days. Median survival in the iMRI group is 396 days, with an interquartile range of 191-599 days (P =0.81). Clinical performance did not differ either. For HRQOL only descriptive statistics were applied due to a limited sample size. Conclusion: This interim analysis of a randomized trial on iMRI-guided glioblastoma resection compared with cNN-guided glioblastoma resection does not show an advantage with respect to extent of resection, clinical performance, and survival for the iMRI group. Ultra-low-field strength iMRI does not seem to be cost-effective compared with cNN, although the lack of a valid endpoint for neurosurgical studies evaluating extent of glioblastoma resection is a limitation of our study and previous volumetry-based studies on this topic.


Neurosurgical Review | 2015

The start and development of epilepsy surgery in Europe: a historical review

Olaf E.M.G. Schijns; Govert Hoogland; Pieter L. Kubben; Peter J. Koehler

Epilepsy has not always been considered a brain disease, but was believed to be a demonic possession in the past. Therefore, trepanation was done not only for medical but also for religious or spiritual reasons, originating in the Neolithic period (3000 BC). The earliest documentation of trepanation for epilepsy is found in the writings of the Hippocratic Corpus and consisted mainly of just skull surgery. The transition from skull surgery to brain surgery took place in the middle of the nineteenth century when the insight of epilepsy as a cortical disorder of the brain emerged. This led to the start of modern epilepsy surgery. The pioneer countries in which epilepsy surgery was performed in Europe were the UK, Germany, and The Netherlands. Neurosurgical forerunners like Sir Victor Horsley, William Macewen, Fedor Krause, and Otfrid Foerster started with “modern” epilepsy surgery. Initially, epilepsy surgery was mainly done with the purpose to resect traumatic lesions or large surface tumours. In the course of the twentieth century, this changed to highly specialized microscopic navigation-guided surgery to resect lesional and non-lesional epileptogenic cortex. The development of epilepsy surgery in Southern Europe, which has not been described until now, will be elaborated in this manuscript. To summarize, in this paper, we provide (1) a detailed description of the evolution of European epilepsy surgery with special emphasis on the pioneer countries; (2) novel, never published information about the development of epilepsy surgery in Southern Europe; and (3) we review the historical dichotomy of invasive electrode implantation strategy (Anglo-Saxon surface electrodes versus French-Italian stereoencephalography (SEEG) model).


Surgical Neurology International | 2012

Correlation between contrast enhancement on intraoperative magnetic resonance imaging and histopathology in glioblastoma.

Pieter L. Kubben; Pieter Wesseling; M.M.Y. Lammens; Olaf E.M.G. Schijns; M. ter Laal-Poort; J.J. van Overbeeke; H. van Santbrink

Object: Glioblastoma is a highly malignant brain tumor, for which standard treatment consists of surgery, radiotherapy, and chemotherapy. Increasing extent of tumor resection (EOTR) is associated with prolonged survival. Intraoperative magnetic resonance imaging (iMRI) is used to increase EOTR, based on contrast enhanced MR images. The correlation between intraoperative contrast enhancement and tumor has not been studied systematically. Methods: For this prospective cohort study, we recruited 10 patients with a supratentorial brain tumor suspect for a glioblastoma. After initial resection, a 0.15 Tesla iMRI scan was made and neuronavigation-guided biopsies were taken from the border of the resection cavity. Scores for gadolinium-based contrast enhancement on iMRI and for tissue characteristics in histological slides of the biopsies were used to calculate correlations (expressed in Kendalls tau). Results: A total of 39 biopsy samples was available for further analysis. Contrast enhancement was significantly correlated with World Health Organization (WHO) grade (tau 0.50), vascular changes (tau 0.53), necrosis (tau 0.49), and increased cellularity (tau 0.26). Specificity of enhancement patterns scored as “thick linear” and “tumor-like” for detection of (high grade) tumor was 1, but decreased to circa 0.75 if “thin linear” enhancement was included. Sensitivity for both enhancement patterns varied around 0.39-0.48 and 0.61-0.70, respectively. Conclusions: Presence of intraoperative contrast enhancement is a good predictor for presence of tumor, but absence of contrast enhancement is a bad predictor for absence of tumor. The use of gadolinium-based contrast enhancement on iMRI to maximize glioblastoma resection should be evaluated against other methods to increase resection, like new contrast agents, other imaging modalities, and “functional neurooncology” – an approach to achieve surgical resection guided by functional rather than oncological-anatomical boundaries.


Surgical Neurology International | 2011

QR codes in neurosurgery.

Pieter L. Kubben

Everyone of you will be familiar with the linear bar codes that are used in shops, or maybe for patient identification in your hospital. Dedicated bar code scanners are used to link the bar code to a specific type of information, like a product price in a shop or a patient identity in a hospital. Using modern information technology, the use of bar codes can be much more than just these examples. Smartphones with integrated cameras can be used to recognize bar codes and link them to products or new information sources (website, multimedia, and address). This development leads to a need for more advanced bar codes that would offer: easy and fast recognition, and a wider range of individual bar codes to reliably identify all information sources.


Stereotactic and Functional Neurosurgery | 2016

TREMOR12: An Open-Source Mobile App for Tremor Quantification

Pieter L. Kubben; Mark L. Kuijf; Linda Ackermans; Albert F.G. Leentjes; Yasin Temel

Background: Evaluating the effect of treatment of tremor is mostly performed with clinical rating scales. Mobile applications facilitate a more rapid, objective, and quantitative evaluation of treatment effect. Existing mobile apps do not offer raw data access, which limits algorithm development. Objective: To develop a novel open-source mobile app for tremor quantification. Methods: TREMOR12 is an open-source mobile app that samples acceleration, rotation, rotation speed, and gravity, each in 3 axes and time-stamped in a frequency up to 100 Hz. The raw measurement data can be exported as a comma-separated value file for further analysis in the TREMOR12P data processing module. The app was evaluated with 3 patients suffering from essential tremor, who were between 55 and 71 years of age. Results: This proof-of-concept study shows that the TREMOR12 app is able to detect and register tremor characteristics such as acceleration, rotation, rotation speed, and gravity in a simple and nonburdensome way. The app is compatible with current regulatory oversight by the European Union (MEDDEV regulations) and the Food and Drug Administration (FDA) guidance on mobile medical applications. Conclusion: TREMOR12 offers low-cost tremor quantification for research purposes and algorithm development, and may help to improve treatment evaluation.


Surgical Neurology International | 2011

An evidence-based mobile decision support system for subaxial cervical spine injury treatment.

Pieter L. Kubben; H van Santbrink; Erwin M. J. Cornips; Alex R. Vaccaro; Marcel F. Dvorak; L W van Rhijn; Albert Scherpbier; H Hoogland

Bringing evidence to practice is a key issue in modern medicine. The key barrier to information searching is time. Clinical decision support systems (CDSS) can improve guideline adherence. Mounting evidence exists that mobile CDSS on handheld computers support physicians in delivering appropriate care to their patients. Subaxial cervical spine injuries account for almost half of spine injuries, and a majority of spinal cord injuries. A valid and reliable classification exists, including evidence-based treatment algorithms. A mobile CDSS on this topic was not yet available. We developed and tested an iPhone application based on the Subaxial Injury Classification (SLIC) and 5 evidence-based treatment algorithms for the surgical approach to subaxial cervical spine injuries. The application can be downloaded for free. Users are cordially invited to provide feedback in order to direct further development and evaluation of CDSS for traumatic lesions of the spinal column.


Frontiers in Integrative Neuroscience | 2015

Is there still need for microelectrode recording now the subthalamic nucleus can be well visualized with high field and ultrahigh MR imaging

Ersoy Kocabicak; Onur Alptekin; Linda Ackermans; Pieter L. Kubben; Mark L. Kuijf; Erkan Kurt; Rianne A. J. Esselink; Yasin Temel

Citation: Kocabicak E, Alptekin O, Ackermans L, Kubben P, Kuijf M, Kurt E, Esselink R and Temel Y (2015) Is there still need for microelectrode recording now the subthalamic nucleus can be well visualized with high field and ultrahigh MR imaging? Front. Integr. Neurosci. 9:46. doi: 10.3389/fnint.2015.00046 Is there still need for microelectrode recording now the subthalamic nucleus can be well visualized with high field and ultrahigh MR imaging?

Collaboration


Dive into the Pieter L. Kubben's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ersoy Kocabicak

Ondokuz Mayıs University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge